Samples from 34 primary transitional cell carcinomas (TCCs) of the bladder were short-term-cultured and processed for cytogenetic analysis after G-banding of the chromosomes. Clonal chromosome abnormalities were detected in 27 tumors and normal karyotypes in 3, and the cultures from 4 tumors failed
Expression of mage genes in transitional-cell carcinomas of the urinary bladder
✍ Scribed by Jean-Jacques Patard; Francis Brasseur; Sixtina Gil-Diez; François Radvanyi; Marie Marchand; Philippe François; Antoine Abi-Aad; Paul Van Cangh; Clément Claude Abbou; Dominique Chopin; Thierry Boon
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 535 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Human genes MAG€-I and MAG€-3 code for distinct antigens, which are recognized on melanoma cells by autologous cytolytic T lymphocytes (CTL). These antigens may constitute useful targets for anti-cancer immunotherapy, since no expression of MAGE genes has been observed in normal tissues other than testis. Out of 57 samples of primary transitional-cell carcinomas of the bladder, I 2 (2 I YO) expressed MAGE-I and 20 (35%) expressed MAGE-3. All but one of the tumors expressing MAGE-I also expressed MACE-3. Genes MACE-2 and MACE-4. which are closely related to MAGE-I and MAGE-3, were expressed by 30% and 33% of the tumors respectively. MAGE expression was more frequent in advanced tumor stages: 6 I Yo
📜 SIMILAR VOLUMES
TAAs of the MAGE family are mostly studied as targets of specific immune responses. Their potential relevance as tumor markers has also been underlined. We used a MAb, 57B, recognizing MAGE-A4 protein in paraffin-embedded sections, to evaluate its expression in bladder cancers by employing TMA inclu